Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV

NCT02559414 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02559414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiplatelet Therapy in HIV - Antiplatelet and Immune Modulating Effects of Aspirin or Clopidogrel in Subjects With HIV
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
February 28, 2017
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hiv, inflammation